Retroperitoneal Hemorrhage in Patients with COVID-19 Undergoing Hemodialysis: Three Case Reports.

Abstract

A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVID-19. Heparin was added, and iliacus hemorrhage developed. Despite heparin discontinuation, he died of worsening pneumonia. A 74-year-old man undergoing hemodialysis was admitted with severe COVID-19. Gastrointestinal bleeding developed during continuous hemodiafiltration with heparin. Upon switching to nafamostat and increasing the dose, iliopsoas hemorrhage developed. Despite interventional radiology, he died of infectious complications. Attention to hemorrhagic complications is therefore needed in patients with COVID-19.

• Authors: Hideaki Oka, Yoshito Homma, Yuki Nishino, Koichiro Suemori, Norio Sato, Yuko Sakurai, Mizuki Sekimoto, Shota Ando, Saki Iwamoto, Takaki Iwamoto, Mika Kondo, Taro Kamimura, Toshiaki Nakano, Takanari Kitazono
• Journal: Internal medicine (Tokyo, Japan) (Intern Med) Vol. 61 Issue 12 Pg. 1869-1876 (Jun 15 2022) ISSN: 1349-7235 [Electronic] Japan
• PMID: 35400699 (Publication Type: Case Reports, Journal Article)

Chemical References

• Anticoagulants
• Heparin

Topics

• Aged
• Anticoagulants (adverse effects)
• COVID-19 (complications)
• Hemorrhage (drug therapy)
• Heparin (therapeutic use)
• Humans
• Male
• Renal Dialysis (adverse effects)